- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Triple-Negative Breast Cancer (TNBC)
Total 11746 results
-
Massachusetts General HospitalTesaro, Inc.RecruitingTriple Negative Breast Cancer | Residual DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma Inc; Medivation, Inc.Active, not recruitingBreast Cancer | Triple Negative Breast Cancer | Early StageUnited States
-
Fudan UniversityTerminated
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedBreast CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterBellicum PharmaceuticalsNot yet recruitingBreast Cancer | Triple Negative Breast Cancer | Relapse | Resistant CancerUnited States
-
Kathy MillerGenentech, Inc.RecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | Estrogen-receptor-low Breast CancerUnited States
-
Centre Francois BaclesseRecruiting
-
Xiang ZhangMirati Therapeutics Inc.TerminatedBreast Neoplasms | Triple Negative Breast Cancer | Breast Cancer Stage IV | Breast Cancer MetastaticUnited States
-
Jo ChienMerck Sharp & Dohme LLCCompletedTriple Negative Breast Cancer | Advanced or Metastatic Breast CancerUnited States
-
University of Colorado, DenverCompletedMetastatic Breast Cancer | Solid TumorsUnited States
-
Dana-Farber Cancer InstituteWithdrawnBreast Cancer | Breast Neoplasms | Breast Carcinoma | Triple Negative Breast Cancer | Breast Cancer Stage II | Breast Cancer Stage III | Early Stage Triple-Negative Breast CarcinomaUnited States
-
Miguel Martín JiménezUNC Lineberger Comprehensive Cancer Center; Hospital Universitario Ramon y... and other collaboratorsActive, not recruitingBreast Cancer | Breast Cancer Stage II-IIISpain
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingBreast Cancer | Triple Negative Breast Cancer | Cardiovascular ComplicationsUnited States
-
St Vincent's Hospital, SydneyRecruitingTriple Negative Breast CancerAustralia
-
Grand Hôpital de CharleroiCliniques universitaires Saint-Luc- Université Catholique de LouvainCompletedBreast Cancer | Triple Negative Breast Cancer | Luminal BBelgium
-
Pennington Biomedical Research CenterRecruitingBreast NeoplasmsUnited States
-
Yale UniversityCompletedBreast NeoplasmsUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingBreast Cancer | Chemotherapy EffectChina
-
Kari WisinskiNovartis; University of Wisconsin, Madison; Big Ten Cancer Research ConsortiumRecruiting
-
Rexahn Pharmaceuticals, Inc.TerminatedSolid Tumor | Triple Negative Breast CancerUnited States
-
Hebei Medical University Fourth HospitalBeijing 302 Hospital; CSPC Ouyi Pharmaceutical Co., Ltd.UnknownTriple Negative Breast Cancer | Nab-paclitaxelChina
-
Luz A. Venta, MDCompletedBreast Cancer | Triple Negative Breast Cancer | Emotions | ImmunologyUnited States
-
AstraZenecaCompletedAdvanced Castrate-resistant Prostate Cancer CRPC | Squamous Non-Small Cell Lung Cancer sqNSCLC | Triple Negative Breast Cancer TNBCSpain, Canada, United States, United Kingdom
-
West Cancer CenterPuma Biotechnology, Inc.; Celcuity IncActive, not recruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | Early-stage Breast CancerUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Triple-Negative Breast Carcinoma | HER2-Negative Breast Carcinoma | Hormone Receptor-Negative Breast CarcinomaUnited States
-
US Oncology ResearchTranslational Drug Development; Life Technologies, Inc.CompletedMetastatic Breast Cancer | Triple Negative Breast CancerUnited States
-
Laura M. Spring, MDMerck Sharp & Dohme LLC; Translational Breast Cancer Research Consortium; Breast...RecruitingTriple Negative Breast Cancer | Hormone Receptor Positive (HR+), HER2-negative Breast Cancer | Biopsy-proven, Positive Lymph Node(s)United States
-
National Cancer Institute (NCI)GlaxoSmithKlineCompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Invasive Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
European Institute of OncologyRecruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Neoadjuvant ChemotherapyItaly
-
West German Study GroupMerck Sharp & Dohme LLC; Gilead SciencesNot yet recruiting
-
AstraZenecaDaiichi SankyoRecruitingBreast CancerUnited States, Spain, United Kingdom, Korea, Republic of, Philippines, Canada, Germany, Italy, Poland, Belgium, Mexico, Japan, France, Brazil, Taiwan, Thailand, Hungary, Turkey, China, India, South Africa, Singapore, Argentina
-
University College Hospital, IbadanUniversity of Chicago; Lagos State University; Obafemi Awolowo University Teaching... and other collaboratorsRecruiting
-
Institut Cancerologie de l'OuestSIRIC ILIADCompletedTriple Negative Breast CancerFrance
-
ERYtech PharmaTerminatedTriple Negative Breast CancerSpain, Belgium, Hungary
-
Merck Sharp & Dohme LLCCompleted
-
GTxTerminatedTriple Negative Breast CancerUnited States
-
Xiaoming XieUnknown
-
Samsung Medical CenterRecruitingTriple Negative Breast Cancer | Immune Checkpoint InhibitorKorea, Republic of
-
National University Hospital, SingaporeMerck Sharp & Dohme LLC; Adagene IncRecruitingTriple Negative Breast Cancer | Advanced Solid TumorSingapore
-
Zhejiang Cancer HospitalSun Yat-sen University; Fujian Cancer Hospital; Hunan Cancer Hospital; Zhejiang... and other collaboratorsNot yet recruitingTriple Negative Breast Cancer | Homologous Recombination Deficiency
-
Gilead SciencesMerck Sharp & Dohme LLCRecruitingTriple Negative Breast Cancer | PD-L1 PositiveUnited States, Taiwan, Belgium, Australia, Austria, Israel, Spain, Italy, Korea, Republic of, Japan, France, Netherlands, Canada, Turkey, Germany, Malaysia, Singapore, United Kingdom, Hong Kong, Hungary, Mexico, Switzerland, Puerto... and more
-
TransThera Sciences (Nanjing), Inc.Active, not recruitingAdvanced Solid Tumors | Triple Negative Breast CancerUnited States, China
-
H. Lee Moffitt Cancer Center and Research InstituteFlorida Breast Cancer FoundationRecruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor-positive Breast CancerUnited States
-
HutchmedActive, not recruitingRectal Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Triple Negative Breast Cancer | Metastatic Colon Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerUnited States
-
Bryan Schneider, MDHoosier Cancer Research Network; Walther Cancer Institute; Vera Bradley Foundation... and other collaboratorsCompletedBreast Cancer | Malignant Neoplasm of BreastUnited States
-
PfizerCompletedNeoplasmUnited States, Spain, Canada, Italy, United Kingdom
-
Milton S. Hershey Medical CenterRecruitingBreast Cancer | Contrast Enhanced UltrasoundUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Federico II University; Humanitas Clinical and Research Center; Istituto Oncologico... and other collaboratorsRecruitingBreast Cancer | Triple Negative Breast Cancer | Fasting | Dietary ExposureItaly
-
Duke UniversityAstraZenecaCompletedTriple Negative Breast CancerUnited States